Australian Clinical Labs Limited
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ACL.AX | LH | NEO | 300463.SZ | ICLR | IMDX | |
|---|---|---|---|---|---|---|
| Market cap | 596.86M | 29.86B | 2.22B | 5.55B | 15.22B | 86.72M |
| P/E (TTM) | 26.7 | 30.1 | — | — | 81.2 | — |
| Forward P/E | 15.3 | 18.8 | 54.5 | 10.6 | 17.5 | -3.3 |
| Price/book | 4.0 | 3.4 | 2.8 | 0.9 | 1.7 | -4.1 |
| Dividend yield | 4.10% | 0.78% | — | — | — | — |
| 1-year change | +21.46% | +41.18% | +61.36% | −23.74% | +26.94% | −58.86% |
| Today | +0.95% | +3.92% | +1.90% | +1.32% | −0.32% | −3.28% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 20 min.
Latest news
All ACL.AX news ›Healius vs Australian Clinical Labs: Which ASX pathology share wins?
Healius and Australian Clinical Labs are both top pathology providers, but one stands out for profits, dividends, and recent momentum. Healius is one of Australia's largest pathology service providers, operating under well-known brands…
Citigroup Declared Substantial Shareholder in Australian Clinical Labs with 5.12% Voting Stake
Kalkine Media Australian Clinical Labs Ltd (ASX:ACL) ACL (ASX:ACL) has been notified of an initial substantial shareholding by Citigroup Global Markets Australia Pty Limited along with its related entities
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- fool.com.au1
- kalkinemedia.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.